Patent details

Basic Information

Publication number:

EP1755650

PCT Application Number:

PCT/US/2005/017914

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057531311

PCT Publication Number:

WO/2005/115333

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

A BIOMOLECULE-CONTAINING SUSPENSION FORMULATION OF INCREASED STABILITY DELIVERABLE VIA AN IMPLANTABLE DELIVERY DEVICE

French Title of Invention:

UNE SUSPENSION CONTENANT UNE BIOMOLÉCULE - D'UNE STABILITÉ AUGMENTÉE ET D'UNE ADMINISTRATION PAR UN DISPOSITIF IMPLANTABLE

German Title of Invention:

EINE BIOMOLEKÜLE ENTHALTENDE SUSPENSIONSFORMULIERUNG VON ERHÖHTER STABILITÄT - FREISETZBAR ÜBER EIN IMPLANTIERBARES HILFSMITTEL

SPC Number:

Dates

Filing date:

23/05/2005

Grant date:

09/07/2008

EP Publication Date:

09/07/2008

PCT Publication Date:

08/12/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/02/2007

EP B1 Publication Date:

09/07/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/05/2009

Expiration date:

23/05/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/05/2005

 

 

Name:

Intarcia Therapeutics Inc.

Address:

24650 Industrial Blvd., Emeryville CA 94545, United States (US)

Inventor

1

Name:

LI Zengji

Address:

United States (US)

2

Name:

LIU Kui

Address:

United States (US)

3

Name:

DESJARDIN Michael A.

Address:

United States (US)

4

Name:

JUNNARKAR Gunjan

Address:

United States (US)

Priority

1

Priority Number:

574662 P

Priority Date:

25/05/2004

Priority Country:

United States (US)

2

Priority Number:

650226 P

Priority Date:

03/02/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/21;

Filing date	Document type	Number of pages